Correction: Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio (PLoS ONE (2017) 12: 3 (e0173947) DOI: 10.1371/journal.pone.0173947);Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Curbelo, Jose ^a   Bueno, Sergio Luquero ^a   Galván Román, José María ^a   Ortega Gómez, Mara ^a   Rajas, Olga ^a   Fernández Jiménez, Guillermo ^a   Vega Piris, Lorena ^a   Rodríguez Salvanes, Francisco ^a   Arnalich, Belén ^b   Díaz, Ana ^a   Costa, Ramón ^a   De La Fuente, Hortensia ^a   Lancho, Ángel ^a   Suárez, Carmen ^a   Ancochea, Julio ^a   Aspa, Javier ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Refractive Surgeon at Clínica Baviera Madrid   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COPEPTIN; PROADRENOMEDULLIN; PROCALCITONIN;

AGE; AGED; ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; LYMPHOCYTE COUNT PERCENTAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL COUNT; NEUTROPHIL COUNT PERCENTAGE; NEUTROPHIL LYMPHOCYTE RATIO; PREDICTION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; UNIVERSITY HOSPITAL; VERY ELDERLY; BLOOD; COMMUNITY ACQUIRED INFECTION; COMPARATIVE STUDY; LYMPHOCYTE; NEUTROPHIL; PNEUMONIA;

AGED; AGED, 80 AND OVER; BIOMARKERS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFLAMMATION; LYMPHOCYTES; MALE; NEUTROPHILS; PATIENT ADMISSION; PNEUMONIA; PROSPECTIVE STUDIES;

EID: 85015649359     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0212915     Document Type: Erratum

References (30)

1. Solomon CG, Wunderink RG, Waterer GW. Community-Acquired Pneumonia. N Engl J Med. 2014; 370: 543-551. https://doi.org/10.1056/NEJMcp1214869 PMID: 24499212
2. Adamuz J, Viasus D, Jiménez-Martínez E, Isla P, Garcia-Vidal C, Dorca J, et al. Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia. J Infect. 2014; 68: 534-541. https://doi.org/10.1016/j.jinf.2014.02.006 PMID: 24534605
3. Yende S, Angus DC, Ali IS, Somes G, Newman AB, Bauer D, et al. Influence of Comorbid Conditions on Long-Term Mortality After Pneumonia in Older People: MORTALITY AFTER PNEUMONIA HOSPITALIZATION. J Am Geriatr Soc. 2007; 55: 518-525.
4. Brancati FL, Chow JW, Wagener MM, Vacarello SJ, Yu VL. Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet Lond Engl. 1993; 342: 30-33.
5. Lim WS, Van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003; 58: 377-382. https://doi.org/10.1136/thorax.58.5.377 PMID: 12728155
6. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336: 243-250. https://doi. org/10.1056/NEJM199701233360402 PMID: 8995086
7. Chalmers JD, Singanayagam A, Akram AR, Mandal P, Short PM, Choudhury G, et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax. 2010; 65: 878-883. https://doi.org/10.1136/thx.2009. 133280 PMID: 20729231
8. Yandiola PPE, Capelastegui A, Quintana J, Diez R, Gorordo I, Bilbao A, et al. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with communityacquired pneumonia. CHEST J. 2009; 135: 1572-1579.
9. Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T. Cardiovascular and Inflammatory Biomarkers to Predict Short-and Long-Term Survival in Community-acquired Pneumonia: Results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med. 2010; 182: 1426-1434. https://doi.org/10.1164/rccm.201003-0415OC PMID: 20639437
10. Viasus D, Del Rio-Pertuz G, Simonetti AF, Garcia-Vidal C, Acosta-Reyes J, Garavito A, et al. Biomarkers for predicting short-term mortality in community-acquired pneumonia: A systematic review and meta-analysis. J Infect. 2016; 72: 273-282. https://doi.org/10.1016/j.jinf.2016.01.002 PMID: 26777314
11. Schuetz P, Suter-Widmer I, Chaudri A, Christ-Crain M, Zimmerli W, Mueller B, et al. Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J. 2011; 37: 384-392. https://doi.org/10. 1183/09031936.00035610 PMID: 20595156
12. Huang DT, Angus DC, Kellum JA, Pugh NA, Weissfeld LA, Struck J, et al. Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia. Chest. 2009; 136: 823-831. https://doi.org/10.1378/chest.08-1981 PMID: 19363212
13. Kolditz M, Halank M, Schulte-Hubbert B, Bergmann S, Albrecht S, Höffken G. Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia. Respir Med. 2012; 106: 1320-1328. https://doi.org/10.1016/j.rmed.2012.06.008 PMID: 22732597
14. Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T. Cardiovascular and Inflammatory Biomarkers to Predict Short-and Long-Term Survival in Community-acquired Pneumonia: Results from the German Competence Network, CAPNETZ. Am J Respir Crit Care Med. 2010; 182: 1426-1434. https://doi.org/10.1164/rccm.201003-0415OC PMID: 20639437
15. Cavallazzi R, El-Kersh K, Abu-Atherah E, Singh S, Loke YK, Wiemken T, et al. Midregional proadrenomedullin for prognosis in community-acquired pneumonia: A systematic review. Respir Med. 2014; 108: 1569-1580. https://doi.org/10.1016/j.rmed.2014.09.018 PMID: 25448309
16. National Institute for Health and Care Excellence (NICE). Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay). In: Guidance and guidelines | NICE [Internet]. 1 Oct 2015 [cited 23 Mar 2016]. https://www.nice.org.uk/guidance/dg18
17. de Jager CPC, Wever PC, Gemen EFA, Kusters R, van Gageldonk-Lafeber AB, van der Poll T, et al. The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia. Eberl M, editor. PLoS ONE. 2012; 7: e46561. https://doi.org/10.1371/journal.pone.0046561 PMID: 23049706
18. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis. 2007; 44: S27-S72. https://doi.org/10.1086/511159 PMID: 17278083
19. Rajas O, Ortega-Gómez M, Román JMG, Curbelo J, Jiménez GF, Piris LV, et al. The incidence of cardiovascular events after hospitalization due to CAP and their association with different inflammatory markers. BMC Pulm Med. 2014; 14: 197. https://doi.org/10.1186/1471-2466-14-197 PMID: 25495677
20. Christ-Crain M, Morgenthaler NG, Stolz D, Mü ller C, Bingisser R, Harbarth S, et al. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care. 2006; 10: R96. https://doi.org/10.1186/cc4955 PMID: 16805922
21. Kolditz M, Halank M, Schulte-Hubbert B, Bergmann S, Albrecht S, Höffken G. Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia. Respir Med. 2012; 106: 1320-1328. https://doi.org/10.1016/j.rmed.2012.06.008 PMID: 22732597
22. Zhydkov A, Christ-Crain M, Thomann R, Hoess C, Henzen C, Zimmerli W, et al. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia. Clin Chem Lab Med CCLM. 2015; 53.
23. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009; 137: 425-428. https://doi.org/10.1016/j.jtcvs.2008.05.046 PMID: 19185164
24. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol EJSO. 2008; 34: 55-60. https://doi.org/10.1016/j.ejso.2007.02.014 PMID: 17448623
25. Han SY, Lee IR, Park SJ, Kim JH, Shin JI. Usefulness of neutrophil-lymphocyte ratio in young children with febrile urinary tract infection. Korean J Pediatr. 2016; 59: 139. https://doi.org/10.3345/kjp.2016.59. 3.139 PMID: 27186221
26. Bozbay M, Uyarel H. Neutrophil-to-lymphocyte ratio: A novel and simple prognostic marker for infective endocarditis. J Crit Care. 2015; 30: 822. https://doi.org/10.1016/j.jcrc.2015.04.115 PMID: 25979271
27. Albrich WC, Dusemund F, Rüegger K, Christ-Crain M, Zimmerli W, Bregenzer T, et al. Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm. BMC Infect Dis. 2011; 11: 1.
28. España PP, Capelastegui A, Mar C, Bilbao A, Quintana JM, Diez R, et al. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia. J Infect. 2015; 70: 457-466. https://doi.org/10.1016/j.jinf.2014.12.003 PMID: 25499199
29. Courtais C, Kuster N, Dupuy A-M, Folschveiller M, Jreige R, Bargnoux A-S, et al. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia. Am J Emerg Med. 2013; 31: 215-221. https://doi.org/10.1016/j.ajem.2012.07.017 PMID: 23000327
30. Bello S, Fandos S, Lasierra AB, MincholéE, Panadero C, Simon AL, et al. Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin. Respir Med. 2015; 109: 1193-1206. https://doi.org/10.1016/j.rmed.2015.07.003 PMID: 26205553